New Leaf Venture Partners, L.L.C. has filed its 13F form on May 14, 2024 for Q1 2024 where it was disclosed a total value porftolio of $114 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arvinas, Inc. with a value of $53.2M, Edgewise Therapeutics, Inc. with a value of $28.3M, Deciphera Pharmaceuticals, Inc. with a value of $9.08M, Crinetics Pharmaceuticals, Inc. with a value of $6.6M, and Rallybio Corp with a value of $6.11M.

Examining the 13F form we can see an decrease of $9.85M in the current position value, from $124M to 114M.

New Leaf Venture Partners, L.L.C. is based out at New York, NY

Below you can find more details about New Leaf Venture Partners, L.L.C. portfolio as well as his latest detailed transactions.

Portfolio value $114 Million
Healthcare: $114 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $114 Million
  • Prior Value $124 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 14, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track New Leaf Venture Partners, L.L.C. Portfolio

Follow New Leaf Venture Partners, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.